References.
Bedi, G., Hyman, D., & de Wit, H. (2010). Is ecstasy an ”empathogen”? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others. Biological Psychiatry, 68(12), 1134-1140. doi: 10.1016/j.biopsych.2010.08.003
Bedi, G., Phan, K. L., Angstadt, M., & de Wit, H. (2009). Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology (Berl), 207(1), 73-83. doi: 10.1007/s00213-009-1635-z
Bentin, S., Allison, T., Puce, A., Perez, E., & McCarthy, G. (1996). Electrophysiological studies of face perception in humans. Journal of Cognitive Neuroscience, 8(6), 551-565. doi: 10.1162/jocn.1996.8.6.551
Bershad, A. K., Miller, M. A., Baggott, M. J., & de Wit, H. (2016). The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants? Journal of Psychopharmacology, 30(12), 1248-1258. doi: 10.1177/0269881116663120
Bershad, A. K., Mayo, L. M., Van Hedger, K., McGlone, F., Walker, S. C., & de Wit, H. (2019). Effects of MDMA on attention to positive social cues and pleasantness of affective touch. Neuropsychopharmacology, 44, 1698-1705. doi: 10.1038/s41386-019-0569-3
Blau, V. C., Maurer, U., Tottenham, N., & McCandliss, B. D. (2007). The face-specific N170 component is modulated by emotional facial expression. Behavioral and Brain Functions, 3, 7. doi: 10.1186/1744-9081-3-7
Borissova, A., et al. (2020). Acute effects of MDMA on trust, cooperative behavior and empathy: A double-blind, placebo-controlled experiment. Journal of Psychopharmacology, 35(5), 547-555. doi: 10.1177/0269881120926673
Cami, J., Farré, M., Mas, M., Roset, P. N., Poudevida, S., Mas, A., San, L., & de la Torre, R. (2000). Human pharmacology of 3,4-methylenedioxymethamphetamine (”ecstasy”): Psychomotor performance and subjective effects. Journal of Clinical Psychopharmacology, 20(4), 455-466. doi: 10.1097/00004714-200008000-00010
Carlyle M, Stevens T, Fawaz L, Marsh B, Kosmider S, Morgan CJ. Greater empathy in MDMA users. J Psychopharmacol, 33(3), 295-304. doi: 10.1177/0269881119826594. Epub 2019 Feb 5. PMID: 30717615.
Carretié, L., Iglesias, J., García, T., & Ballesteros, M. (1997). N300, P300 and the emotional processing of visual stimuli. Electroencephalography and Clinical Neurophysiology, 103(2), 298-303. doi: 10.1016/s0013-4694(96)96565-7
Chaudhri, N., Caggiula, A. R., Donny, E. C., Booth, S., Gharib, M., Craven, L., Palmatier, M. I., Liu, X., & Sved, A. F. (2007). Self-administered and noncontingent nicotine enhance reinforced operant responding in rats: impact of nicotine dose and reinforcement schedule. Psychopharmacology (Berl), 190(3), 353-362. doi: 10.1007/s00213-006-0454-8
Danforth, A. L., Grob, C. S., Struble, C., Feduccia, A. A., Walker, N., Jerome, L., Yazar-Klosinski, B., & Emerson, A. (2018). Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Psychopharmacology (Berl), 235(11), 3137-3148. doi: 10.1007/s00213-018-5010-9
Doss, M. K., Weafer, J., Gallo, D. A., & de Wit, H. (2018). MDMA Impairs Both the Encoding and Retrieval of Emotional Recollections. Neuropsychopharmacology, 43(4), 791-800. doi: 10.1038/npp.2017.171
Gough, B., Ali, SF., Slikker, W. Jr., & Holson, R. R. (1991). Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate. Pharmacol Biochem Behav, 39(3), 619-623. doi: 10.1016/0091-3057(91)90137-q
Heifets, B. D., Salgado, J. S., Taylor, M. D., Hoerbelt, P., Cardozo Pinto, D. F., Steinberg, E. E., Walsh, J. J., Sze, J. Y., & Malenka, R. C. (2019). Distinct neural mechanisms for the prosocial and rewarding properties of MDMA. Sci Transl Med, 11(522). doi: 10.1126/scitranslmed.aaw6435
Hiris, E. (2007). Detection of biological and nonbiological motion. Journal of Vision, 7(12), 1-16. https://doi.org/10.1167/7.12.4
Holze, F., Vizeli, P., Müller, F., Ley, L., Duerig, R., Varghese, N., Eckert, A., Borgwardt, S., & Liechti, M. E. (2020). Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects. Neuropsychopharmacology, 45(3), 462-471. doi: 10.1038/s41386-019-0569-3
Hysek, C. M., Schmid, Y., Simmler, L. D., Domes, G., Heinrichs, M., Eisenegger, C., Preller, K. H., Quednow, B. B., & Liechti, M. E. (2014). MDMA enhances emotional empathy and prosocial behavior. Social Cognitive and Affective Neuroscience, 9(11), 1645-1652. doi: 10.1093/scan/nst161
Kalant, H. (2001). The pharmacology and toxicology of ”ecstasy” (MDMA) and related drugs. Canadian Medical Association Journal, 165(7), 917-928. PMID: 11599334; PMCID: PMC81503
Kamilar-Britt, P., & Bedi, G. (2015). The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals. Neuroscience and Biobehavioral Reviews, 57, 433-446. doi: 10.1016/j.neubiorev.2015.08.016
Kirkpatrick, M. G., & de Wit, H. (2015). MDMA: A social drug in a social context. Psychopharmacology (Berl), 232(6), 1155-1163. doi: 10.1007/s00213-014-3752-6
Kirkpatrick, M. G., Lee, R., Wardle, M. C., Jacob, S., & de Wit, H. (2014). Effects of MDMA and intranasal oxytocin on social and emotional processing. Neuropsychopharmacology, 39(7), 1654-1663. doi: 10.1038/npp.2014.12
Kirkpatrick, M. G., Delton, A. W., Robertson, T. E., & de Wit, H. (2015). Prosocial effects of MDMA: A measure of generosity. Journal of Psychopharmacology, 29, 661-668. PMID: 25735993
Kret, M. E., & De Gelder, B. (2012). A review on sex differences in processing emotional signals. Neuropsychologia, 50(7), 1211-1221. doi: 10.1016/j.neuropsychologia.2011.12.022
Kuypers, K. P. C., de la Torre, R., Farre, M., Pizarro, N., Xicota, L., & Ramaekers, J. G. (2018). MDMA-induced indifference to negative sounds is mediated by the 5-HT2A receptor. Psychopharmacology (Berl), 235(2), 481-490. doi: 10.1007/s00213-017-4699-1
Le Sommer, J., Low, A. M., Møllegaard Jepsen, J. R., Fagerlund, B., Vangkilde, S., Habekost, T., Glenthøj, B., & Oranje, B. (2023). Effects of methylphenidate on mismatch negativity and P3a amplitude of initially psychostimulant-naïve, adult ADHD patients. Psychological Medicine, 53(3), 957-965. doi: 10.1017/S0033291721002373
Luethi, D., & Liechti, M. E. (2020). Designer drugs: Mechanism of action and adverse effects. Archives of Toxicology, 94(4), 1085-1133. doi: 10.1007/s00204-020-02693-7
Mejias, S., Rossignol, M., Debatisse, D., Streel, E., Servais, L., Guérit, J. M., Philippot, P., Campanella, S. (2005). Event-related potentials (ERPs) in ecstasy (MDMA) users during a visual oddball task. Biological Psychology, 69(3), 333-352. doi: 10.1016/j.biopsycho.2004.11.010
Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., … Doblin, R. (2021). MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine, 27(6), 1025-1033. doi: 10.1038/s41591-021-01336-3
Morgan, H. M., Klein, C., Boehm, S. G., Shapiro, K. L., Linden, D. E. (2008). Working memory load for faces modulates P300, N170, and N250r. Journal of Cognitive Neuroscience, 20(6), 989-1002. doi: 10.1162/jocn.2008.20072
Mueller, C. J., Fritsch, N., Hofmann, M. J., Kuchinke, L. (2017). Differences in the dynamics of affective and cognitive processing – An ERP study. Brain Research, 1655, 41-47. doi: 10.1016/j.brainres.2016.11.018
Nardou, R., Lewis, E. M., Rothhaas, R., Xu, R., Yang, A., Boyden, E., & Dölen, G. (2019). Oxytocin-dependent reopening of a social reward learning critical period with MDMA. Nature, 569(7754), 116-120. doi: 10.1038/s41586-019-1075-9
Peltola, M. J., Strathearn, L., Puura, K. (2018). Oxytocin promotes face-sensitive neural responses to infant and adult faces in mothers. Psychoneuroendocrinology, 91, 261-270. doi: 10.1016/j.psyneuen.2018.02.012. PMID: 29478725
Peroutka, S. J., Newman, H., & Harris, H. (1988). Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology, 1(4), 273-277. PMID: 2908020
Qiu, R., Wang, H., & Fu, S. (2017). N170 reveals the categorical perception effect of emotional valence. Frontiers in Psychology, 8, 2056. doi: 10.3389/fpsyg.2017.02056. PMID: 29225590; PMCID: PMC5705631
Raz, S., Dan, O., & Zysberg, L. (2014). Neural correlates of emotional intelligence in a visual emotional oddball task: An ERP study. Brain and Cognition, 91, 79-86. doi: 10.1016/j.bandc.2014.09.003. PMID: 25265320
Rosburg, T., Weigl, M., & Deuring, G. (2019). Enhanced processing of facial emotion for target stimuli. International Journal of Psychophysiology, 146, 190-200. doi: 10.1016/j.ijpsycho.2019.08.010. PMID: 31669316
Schindler, S., & Bublatzky, F. (2020). Attention and emotion: An integrative review of emotional face processing as a function of attention. Cortex, 130, 362-386. doi: 10.1016/j.cortex.2020.06.010. PMID: 32745728
Schmid, Y., Hysek, C. M., Simmler, L. D., Crockett, M. J., Quednow, B. B., & Liechti, M. E. (2014). Differential effects of MDMA and methylphenidate on social cognition. Journal of Psychopharmacology, 28(9), 847-856. doi: 10.1177/0269881114542454. PMID: 25052243
Schmidt, A., Müller, F., Dolder, P. C., Schmid, Y., Zanchi, D., Egloff, L., Liechti, M. E., & Borgwardt, S. (2018). Acute effects of methylphenidate, modafinil, and MDMA on negative emotion processing. International Journal of Neuropsychopharmacology, 21(4), 345-354. doi: 10.1093/ijnp/pyx112. PMID: 29206921; PMCID: PMC5887414
Silber, B., Croft, R., Camfield, D. A., Downey, L. A., Papafotiou, K., & Stough, C. (2012). The acute effects of d-amphetamine and d-methamphetamine on ERP components in humans. European Neuropsychopharmacology, 22(7), 492-500. doi: 10.1016/j.euroneuro.2011.11.009. PMID: 22209365
Simmler LD, Buser TA, Donzelli M, Schramm Y, Dieu LH, Huwyler J, Chaboz S, Hoener MC, Liechti ME. (2013). Pharmacological characterization of designer cathinones in vitro. British Journal of Pharmacology, 168(2), 458-470. doi: 10.1111/j.1476-5381.2012.02145.x. PMID: 22897747; PMCID: PMC3572571.
Stefanics, G., Kremláček, J., & Czigler, I. (2014). Visual mismatch negativity: A predictive coding view. Frontiers in Human Neuroscience, 8, 666. doi: 10.3389/fnhum.2014.00666. PMID: 25278859; PMCID: PMC4165279.
Tancer, M., & Johanson, C. E. (2003). Reinforcing, subjective, and physiological effects of MDMA in humans: A comparison with d-amphetamine and mCPP. Drug and Alcohol Dependence, 72(1), 33-44. doi: 10.1016/s0376-8716(03)00172-8. PMID: 14563541.
Taylor, J. R., & Robbins, T. W. (1984). Enhanced behavioural control by conditioned reinforcers following microinjections of d-amphetamine into the nucleus accumbens. Psychopharmacology, 84(3), 405-412. doi: 10.1007/BF00555222. PMID: 6440188.
Thompson, M. R., Hunt, G. E., & McGregor, I. S. (2009). Neural correlates of MDMA (”Ecstasy”)-induced social interaction in rats. Social Neuroscience, 4(1), 60-72. doi: 10.1080/17470910802045042. PMID: 18633827.
Umbricht, D., & Krljes, S. (2005). Mismatch negativity in schizophrenia: A meta-analysis. Schizophrenia Research, 76(1), 1-23. doi: 10.1016/j.schres.2004.12.002. PMID: 15927795.
Wardle, M. C., & de Wit, H. (2014). MDMA alters emotional processing and facilitates positive social interaction. Psychopharmacology, 231, 4219-4229. doi: 10.1007/s00213-014-3570-x.
Wardle, M. C., Kirkpatrick, M. G., & de Wit, H. (2014). ’Ecstasy’ as a social drug: MDMA preferentially affects responses to emotional stimuli with social content. Social Cognitive and Affective Neuroscience, 9(8), 1076-1081. doi: 10.1093/scan/nsu035. PMID: 24682132; PMCID: PMC4127030.
White, T. L., Justice, A. J., & de Wit, H. (2002). Differential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacology, Biochemistry, and Behavior, 73(4), 729-741. doi: 10.1016/s0091-3057(02)00818-3. PMID: 12213517.
Wienberg, M., Glenthoj, B. Y., Jensen, K. S., & Oranje, B. (2010). A single high dose of escitalopram increases mismatch negativity without affecting processing negativity or P300 amplitude in healthy volunteers. Journal of Psychopharmacology, 24(8), 1183-1192. doi: 10.1177/0269881109102606. PMID: 19304862.
Wunderli MD, Vonmoos M, Treichler L, Zeller C, Dziobek I, Kraemer T, Baumgartner MR, Seifritz E, Quednow BB. (2018). Social Cognition and Interaction in Chronic Users of 3,4-Methylenedioxymethamphetamine (MDMA, ”Ecstasy”). International Journal of Neuropsychopharmacology, 21(4), 333-344. doi: 10.1093/ijnp/pyx098. PMID: 29087534; PMCID: PMC5888715.